Indeed, sPD-1 and sPD-L2 levels are elevated in SSc patients and this correlates with severity of disease, as well as an increase in TNF-α producing B cells and a reduction in IL-10 producing B cells (56, 58). Here, IL10 is linked to systemic sclerosis.